The Pseudotumor Cerebri Syndrome.

Idiopathic intracranial hypertension Obesity Optical coherence tomography Papilledema Pseudotumor cerebri

Journal

Neurologic clinics
ISSN: 1557-9875
Titre abrégé: Neurol Clin
Pays: United States
ID NLM: 8219232

Informations de publication

Date de publication:
May 2024
Historique:
medline: 5 4 2024
pubmed: 5 4 2024
entrez: 4 4 2024
Statut: ppublish

Résumé

Pseudotumor cerebri syndrome is a syndrome of increased cerebrospinal fluid pressure without ventriculomegaly, mass lesion, or meningeal abnormality. It is either primary (idiopathic intracranial hypertension, IIH) or secondary. A secondary cause is unlikely when adhering to the diagnostic criteria. Permanent visual loss occurs if undetected or untreated, and the associated headaches may be debilitating. Fulminant disease may result in blindness despite aggressive treatment. This study addresses the diagnosis and management of IIH including new insights into the pathobiology of IIH, updates in therapeutics and causes of overdiagnosis.

Identifiants

pubmed: 38575259
pii: S0733-8619(24)00001-X
doi: 10.1016/j.ncl.2024.02.001
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

433-471

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure Dr D.I. Friedman served on advisory boards for Abbvie, Collegium, Eli Lilly, Impel NeuroPharma, Lundbeck, Pfizer, and Zosano Pharmaand and as a speaker for Abbvie and Impel Neuropharma. She is a consultant for Pfizer. She is on the editorial board of Neurology Reviews and the Journal of Neuro-Ophthalmology, medical advisor to the Spinal CSF Leak Foundation and HealthyWomen, and on the Board of Directors of the Southern Headache Society.

Auteurs

Deborah I Friedman (DI)

Yellow Rose Headache and Neuro-Ophthalmology. Electronic address: DeborahFriedman@tx.rr.com.

Classifications MeSH